In the latest quarter, 6 analysts provided ratings for Ovid Therapeutics (NASDAQ:OVID), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 1 | 1 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 3 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
Analysts have recently evaluated Ovid Therapeutics and provided 12-month price targets. The average target is $6.92, accompanied by a high estimate of $9.00 and a low estimate of $3.00. Experiencing a 5.59% decline, the current average is now lower than the previous average price target of $7.33.
Investigating Analyst Ratings: An Elaborate Study
The perception of Ovid Therapeutics by...
Login or create a forever free account to read this news
Sign up/Log in